The combination of PARP/Wee1 inhibition was previously tested in lung and pancreatic cancer cells with similarities but also some differences to our findings in HPV-positive HNSCC cells (61, 62). The gene discussed is PARP1; the disease is head and neck squamous cell carcinoma.